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Endometrial cancer is the most common female cancer in developed countries.1In Indonesia, 
cervical cancer is the fourth most common cancer after cervical cancer, ovarian cancer and malignant 
trophoblastic disease.* Geographic condition and limited number of gynecologic oncologists are 
associated with patients access in oncologic services.
Can gynecologist manage endometrial cancer? This is a common question from patients because 
there are many cases of inadequate treatment for endometrial cancer. Gynecologists should be 
competent enough to diagnose endometrial cancer to guide treatment for the patients properly. Finally, 
gynecologists should be competent to treat endometrial cancer in selective patients.
Base on histopathology, endometrial cancer divided into two types. Type 1 is related to unopposed 
estrogen, and the histopathology is endometrioid adenocarcinoma. This type generally is low-grade. 
Type II is mostly high-grade or has histopathology as papillary serous adenocarcinoma or clear cell 
carcinoma. This grouping is crucial because the gynecologist only allowed to manage the low-risk 
group; it means the histopathology must be type I and clinically stage 1A. The reason why gynecologist 
did not have any competency to manage type II endometrial cancer because surgical management is 
different; its surgical staging included pelvic and paraaortic lymphadenectomy. This competency was 
not stated in the curriculum.
How to diagnose endometrial cancer? The procedure can be started from clinical and imaging 
examination to evaluate the tumour mass, including the invasiveness of endometrial cancer. This 
invasiveness can be determined by using ultrasonography examination, computed tomography 
scan and magnetic resonance imaging.2 The golden standard for diagnosingendometrial cancer 
ishistopathological examination. The specimen for histopathology could be taken from endometrial 
biopsy or curettage. Biopsy-guided hysteroscopy is an optional procedure in endometrial cancer in 
Indonesia. However, it is recommended in the United States of America.2-4 One critical point is that 
gynaecologist must be competent to diagnose endometrial cancer based on histopathological 
examination as type 1 and from an image is stage 1A, because only stage 1A endometrial cancer stage 
and well-differentiated endometrioid adenocarcinoma are allowed to betreated by gynecologists. The 
management includes fertility-sparing procedure or other surgical procedures. These competencies 
are stated in the curriculum of Obstetrics and Gynecology speciality program education. The clue 
of fertility-sparing management in endometrial cancer should be based on the basic concept of 
endometrial cell proliferation and cell cycle arrest. Several hormones which have anti-proliferation is 
a modality for fertility-sparing management.4-6Surgical management for low-risk endometrial cancer 
can be managed by hysterectomy with or without bilateral salpingo-oophorectomy. Therefore, every 
education centre must train obstetrics and gynecology residents adequately. The Indonesian Obstetrics 
and Gynecology College is responsible for making this policy, including quality control in this process 
of training, which is this point stated in the logbook. Hopefully, for the next decade, endometrial cancer 
will be managedadequately.
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